News
Trump on US tariff deal with India
Digest more
Johnson & Johnson shrugs off tariff impact
Digest more
Bloomberg on MSN9h
Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&ANovartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...
Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Trump’s latest two industrial sector tariffs—200 percent on pharmaceuticals and 50 percent on copper—have serious ...
2don MSN
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results